EUVIMEDEUVIMED entdecken
Open Access

Evaluating AT1R expression and the effects of renin-angiotensin system inhibition in a mouse model of cerebral amyloid angiopathy

Natalia Motzko Noto, Lisa S Robison, Robert C Speth

Brain Research · 2025

DOI: 10.1016/j.brainres.2025.149999 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2025. Verfasst von Natalia Motzko Noto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA. El…. Hauptthemen laut MEDLINE: Receptor, Angiotensin, Type 1, Cerebral Amyloid Angiopathy, Renin-Angiotensin System, Brain. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, American Heart Association Inc, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The renin-angiotensin-aldosterone system (RAAS) has been shown to be dysregulated in dementia, with elevated levels of angiotensin-converting enzyme (ACE), angiotensin (Ang) II, and Ang II type 1 receptors (AT1Rs). Cerebral amyloid angiopathy (CAA), a dementia-causing cerebrovascular disease, currently has no treatment or cure available. We assessed whether a mouse model with CAA (Tg-SwDI) exhibits elevated levels of AT1Rs and whether RAAS-targeting drugs (telmisartan and lisinopril) affect these levels. MATERIALS AND METHODS: Tg-SwDI mice were treated with sub-depressor doses of either telmisartan or lisinopril from 3 to 8 months of age, with blood pressure being monitored 2 and 4 months after the start of treatment. Post-mortem, receptor autoradiography was performed to determine levels of AT1R in 13 brain regions in untreated and treated Tg-SwDI mice compared to untreated wild-type controls (C57BL/6J mice). RESULTS: No statistically significant differences among groups were observed in AT1R levels in any of the 13 brain regions analyzed. Although sexual dimorphism in blood pressure was observed in both wild-type and Tg-SwDI mice (males > females), drug treatment did not significantly lower blood pressure in Tg-SwDI mice, confirming the delivery of sub-depressor doses. CONCLUSIONS: Regional brain AT1R levels were not significantly dysregulated in Tg-SwDI mice compared to wild-type mice. Additionally, drug treatment with sub-depressor doses of the AT1R antagonist, telmisartan, or the ACE inhibitor, lisinopril, caused no significant brain AT1R alterations in Tg-SwDI mice. This suggests that pathophysiological changes in the brain renin-angiotensin system do not mediate the cognitive impairments and neuropathological changes associated with CAA in Tg-SwDI mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Angiotensin, Type 1Cerebral Amyloid AngiopathyRenin-Angiotensin SystemBrainAnimalsMaleFemaleLisinoprilMiceMice, TransgenicDisease Models, AnimalTelmisartanAngiotensin II Type 1 Receptor BlockersMice, Inbred C57BLBenzimidazolesAngiotensin-Converting Enzyme InhibitorsBenzoatesBlood PressureAutoradiography

Stichwörter der Autor:innen

Cerebral amyloid angiopathyLisinoprilReceptor autoradiographySexual dimorphismTelmisartanTg-SwDI mice

Substanzen

Receptor, Angiotensin, Type 1LisinoprilTelmisartanAngiotensin II Type 1 Receptor BlockersBenzimidazolesAngiotensin-Converting Enzyme InhibitorsBenzoates

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA. Electronic address: nn346@nova.edu.
  • Department of Psychology and Behavioral Neuroscience, College of Psychology, Nova Southeastern University, Fort Lauderdale, FL 33328, USA. Electronic address: lrobiso1@nova.edu.
  • Department of Pharmaceutical Sciences, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA; Department of Pharmacology and Physiology, School of Medicine, Georgetow…

Förderung

  • NIA NIH HHS
  • American Heart Association Inc
  • National Institute on Aging

Zitieren

APA

Motzko Noto, N., Robison, L. S., & Speth, R. C. (2025). Evaluating AT1R expression and the effects of renin-angiotensin system inhibition in a mouse model of cerebral amyloid angiopathy. Brain Research. https://doi.org/10.1016/j.brainres.2025.149999

Vancouver

Motzko Noto N, Robison LS, Speth RC. Evaluating AT1R expression and the effects of renin-angiotensin system inhibition in a mouse model of cerebral amyloid angiopathy. Brain Research. 2025. doi:10.1016/j.brainres.2025.149999

BibTeX
@article{MotzkoNoto2025,
  author = {Motzko Noto, Natalia and Robison, Lisa S and Speth, Robert C},
  title = {Evaluating AT1R expression and the effects of renin-angiotensin system inhibition in a mouse model of cerebral amyloid angiopathy},
  journal = {Brain Research},
  year = {2025},
  doi = {10.1016/j.brainres.2025.149999}
}
Kostenlos starten →